You are here

ALTUS BIOLOGICS, INC.

Company Information
Address
ALTUS BIOLOGICS, INC. 625 PUTNAM AVE
CAMBRIDGE, MA 02139 0480
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. PREVENTION OF BIOFILMS IN MEDICAL DEVICES

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Design of new efficient drug delivery systems for proteins is one of the major themes of modern biotechnology and biopharmaceutical industry. We found that cross-l ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  2. NOVEL PROTEASE FORMULATION BASED ON CROSSLINKED CRYSTALS

    Amount: $0.00

    DESCRIPTION (provided by applicant): Design of stable and efficient formulation of proteins for therapeutic use as drugs has been a major focus of biotechnology and pharmaceutical companies. In the P ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  3. NOVEL PROTEASE FORMULATION BASED ON CROSSLINKED CRYSTALS

    Amount: $750,330.00

    DESCRIPTION (provided by applicant): Design of stable and efficient formulation of proteins for therapeutic use as drugs has been a major focus of biotechnology and pharmaceutical companies. In the P ...

    SBIRPhase II2003Department of Health and Human Services National Institutes of Health
  4. PROTEASE FORMULATION BASED ON CROSSLINKED ENZYME CRYSTAL

    Amount: $100,083.00

    Design of new efficient drug delivery systems for proteins is one of the major themes of modern biotechnology and biopharmaceutical industry. We found that crosslinked enzyme crystals (CLECs(R)) show ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
  5. NOVEL ENZYME FORMULATION FOR TREATMENT OF HYPEROXALURIA

    Amount: $86,724.00

    DESCRIPTION (provided by applicant): Design of new efficient drug delivery systems for proteins is one of the major themes of modern biotechnology and biopharmaceutical industry. We ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
  6. N/A

    Amount: $750,000.00

    N/A

    SBIRPhase II1999Department of Health and Human Services
  7. N/A

    Amount: $100,000.00

    N/A

    SBIRPhase I1999National Science Foundation
  8. SBIR Phase I: Protein Crystals as Novel Materials for Chromatography

    Amount: $75,000.00

    N/A

    SBIRPhase I1997National Science Foundation
  9. PROTEIN DRUG DELIVERY BASED ON STABILIZED PROTEIN

    Amount: $100,000.00

    N/A

    SBIRPhase I1997Department of Health and Human Services
  10. Dehydrogenase Crystals as Catalysts in Organic Synthesis

    Amount: $495,146.00

    Enzyme microcrystals (less than 100 um) grown from aqueous solution and cross-linked witha bifunctional agent such as glutaraldehyde exhibit remarkable characteristics that are superior to bothsoluble ...

    SBIRPhase II1996Department of Health and Human Services
US Flag An Official Website of the United States Government